234 related articles for article (PubMed ID: 30448601)
1. Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Stokkeland K; Höijer J; Bottai M; Söderberg-Löfdal K; Bergquist A
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1860-1866.e1. PubMed ID: 30448601
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
3. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
Lee WS; Karthik SV; Ng RT; Ong SY; Ong C; Chiou FK; Wong SY; Quak SH; Aw MM
Pediatr Neonatol; 2019 Aug; 60(4):396-404. PubMed ID: 31409456
[TBL] [Abstract][Full Text] [Related]
4. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
Charatcharoenwitthaya P; Angulo P; Enders FB; Lindor KD
Hepatology; 2008 Jan; 47(1):133-42. PubMed ID: 17992695
[TBL] [Abstract][Full Text] [Related]
5. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Eaton JE; Silveira MG; Pardi DS; Sinakos E; Kowdley KV; Luketic VA; Harrison ME; McCashland T; Befeler AS; Harnois D; Jorgensen R; Petz J; Lindor KD
Am J Gastroenterol; 2011 Sep; 106(9):1638-45. PubMed ID: 21556038
[TBL] [Abstract][Full Text] [Related]
6. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
7. Novel developments in IBD-related sclerosing cholangitis.
Ponsioen CY
Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S15-8. PubMed ID: 21640925
[TBL] [Abstract][Full Text] [Related]
8. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
9. Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
Levine JS; Burakoff R
Inflamm Bowel Dis; 2007 Oct; 13(10):1293-8. PubMed ID: 17567870
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
Pardi DS; Loftus EV; Kremers WK; Keach J; Lindor KD
Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884
[TBL] [Abstract][Full Text] [Related]
11. [Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
Vetter C
MMW Fortschr Med; 2005 Mar; 147(13):10. PubMed ID: 15832752
[No Abstract] [Full Text] [Related]
12. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
13. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Holtmeier J; Leuschner U
Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
[TBL] [Abstract][Full Text] [Related]
15. Crohn's disease and primary sclerosing cholangitis: a case report and review of the literature.
Miao XP; Sun XN; Wei H; Ouyang Q
Intern Med; 2012; 51(16):2077-81. PubMed ID: 22892482
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.
Schramm C; Schirmacher P; Helmreich-Becker I; Gerken G; zum Büschenfelde KH; Lohse AW
Ann Intern Med; 1999 Dec; 131(12):943-6. PubMed ID: 10610645
[TBL] [Abstract][Full Text] [Related]
17. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid in patients with ulcerative colitis and primary sclerosing cholangitis for prevention of colon cancer: a meta-analysis.
Ashraf I; Choudhary A; Arif M; Matteson ML; Hammad HT; Puli SR; Bechtold ML
Indian J Gastroenterol; 2012 Apr; 31(2):69-74. PubMed ID: 22528343
[TBL] [Abstract][Full Text] [Related]
19. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
[TBL] [Abstract][Full Text] [Related]
20. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]